Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243333 · ClinicalTrials.gov registry record · NA
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01243333 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 26 participants.
The verdict
NCT01243333, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This clinical trial studies multi-tracer positron emission tomography in patients with solid tumors. Diagnostic procedures, such as multi-tracer positron emission tomography, may help measure a patient's response to treatment.
Interventions
- PROCEDURE Positron Emission Tomography
- RADIATION [F-18]fluorodeoxyglucose
- RADIATION [F-18]fluorothymidine
- RADIATION Water O-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-02-02 |
| Est. Completion | 2016-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01243333
The ClinicalTrials.gov registry entry for NCT01243333 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Positron Emission Tomography is the first listed.
NCT01243333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01243333 about?
NCT01243333 is a clinical study titled "Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors". This clinical trial studies multi-tracer positron emission tomography in patients with solid tumors. Diagnostic procedures, such as multi-tracer positron emission tomography, may help measure a patient's response to treatment.
What is the current status of trial NCT01243333?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2011-02-02. Estimated completion is 2016-04-08.
What interventions are being tested in trial NCT01243333?
The interventions under investigation include: Positron Emission Tomography (PROCEDURE), [F-18]fluorodeoxyglucose (RADIATION), [F-18]fluorothymidine (RADIATION), Water O-15 (RADIATION).
Who is sponsoring clinical trial NCT01243333?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.